PreemaTEX Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
PreemaTEX General Information
Description
Developer of diagnostic tests designed to diagnose premature birth. The company's tests focus on assessing a woman's risk for preterm delivery early in pregnancy, enabling physicians and doctors to diagnose the baby and avoid premature deaths.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
- 3500 Sunrise Highway, Building 200
- Suite 111A, Great River
- New York, NY 11739
- United States
Primary Industry
Diagnostic Equipment
Corporate Office
- 3500 Sunrise Highway, Building 200
- Suite 111A, Great River
- New York, NY 11739
- United States
PreemaTEX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Feb-2023 | Completed | Startup | |||
| 1. Early Stage VC | 01-Jan-2014 | Completed | Startup |
PreemaTEX FAQs
-
When was PreemaTEX founded?
PreemaTEX was founded in 2014.
-
Where is PreemaTEX headquartered?
PreemaTEX is headquartered in New York, NY.
-
What industry is PreemaTEX in?
PreemaTEX’s primary industry is Diagnostic Equipment.
-
Is PreemaTEX a private or public company?
PreemaTEX is a Private company.
-
What is PreemaTEX’s current revenue?
The current revenue for PreemaTEX is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process